Jason V. Coloma, CEO: Maze Therapeutics MAZE Sell · Filed 10/02

Trade details

Type: Insider sale
Amount: $70,073.49
Shares · price: 2,593 sh · $27.02 a share
Held after: 15,558 sh
Stock: Maze Therapeutics MAZE
Person: Jason V. ColomaCEO
Trade date: 26/10/01
Filed: 26/10/02
Days to filing: 1 days

Sold 14.3% of holdings

Share of holding sold: 14.3%

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 09/01~10/31

Jason V. Coloma's recent trades

Jason V. ColomaCEO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$862.2K
31,908 sh
$862.2K
Filed 10/02
Traded 10/01
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$933.3K
34,501 sh
$933.3K
Filed 10/01
Traded 10/01
Jason V. ColomaCEO
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$623.4K
23,497 sh
$623.4K
Filed 09/02
Traded 09/02
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$908.1K
34,501 sh
$908.1K
Filed 09/01
Traded 09/01
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$922.6K
34,501 sh
$922.6K
Filed 08/03
Traded 08/03